基于真实世界数据的5年痴呆症预测和决策支持系统
Themis P Exarchos1,2, George A Dimakopoulos1, Konstantinos Lazaros1
1Bioinformatics and Human Electrophysiology Laboratory, Department of Informatics, Ionian University, Corfu, Greece.
Frontiers in aging neuroscience
|October 16, 2025
概括
这项研究开发了一个机器学习模型,使用电子健康记录来预测阿尔茨海默病和相关痴呆症. 该模型实现了72.2%的准确性,为临床决策支持提供了现实的见解.
科学领域:
- 医疗信息学 医疗信息学
- 机器学习 机器学习
- 神经科学是一个神经科学.
背景情况:
- 痴呆风险预测模型经常使用志愿者数据,限制了现实世界的适用性.
- 电子健康记录 (EHR) 提供了现实的数据,但需要广泛的处理用于临床使用.
- 阿尔茨海默病和相关的痴呆症是复杂的,多因素的神经退行性疾病.
研究的目的:
- 开发和验证基于机器学习 (ML) 的痴呆风险预测模型,使用现实世界EHR数据.
- 根据来自多式联络电子健康记录数据的临床特征,确定痴呆症的预后规则集.
- 提高痴呆症预测的临床互操作性和准确性.
主要方法:
- 利用了约翰霍普金斯医疗系统从多式联络电子病历数据的十年出口.
- 开发了一种可解释的二进制分类模型,用于在五年内预测痴呆症发病.
- 雇佣5倍交叉验证用于模型评估.
主要成果:
- 该模型实现了0.722 (95% CI:0.722-0.723) 的平均测试准确度.
- 该模型获得了 0.795 (95% CI: 0.794-0.795) 的接收器操作特征曲线 (AUROC) 下面的面积.
- 根据临床特征确定了痴呆症的预后规则集.
结论:
- 使用现实世界EHR数据的机器学习模型可以准确地预测痴呆症的发病.
- 多模式数据分析和组合效应的建模对于理解痴呆症风险路径至关重要.
- 开发的模型显示了在痴呆症护理中改善临床决策支持的潜力.
更多相关视频
07:31Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
Published on: May 15, 2020
7.5K
08:36The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
Published on: July 28, 2022
4.3K
相关概念视频
01:30Dementia
515
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
515
01:22Alzheimer's Disease: Treatment
811
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
811
01:26Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K